Loomis Sayles & CO L P Alnylam Pharmaceuticals, Inc. Transaction History

Loomis Sayles & CO L P

$79.2 Billion
Q4 2024

A detailed history of Loomis Sayles & CO L P transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Loomis Sayles & CO L P holds 503,045 shares of ALNY stock, worth $123 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

503,045

Previous 525,303 4.24%

Holding current value

$123 Million

Previous $144 Million 18.07%

% of portfolio

0.15%

Previous 0.19%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$232.27 - $300.43 $5.17 Million - $6.69 Million	-22,258 Reduced 4.24%	503,045 $118 Million
Q3 2024 Nov 13, 2024	SELL	$233.81 - $287.01 $10.3 Million - $12.6 Million	-43,979 Reduced 7.73%	525,303 $144 Million
Q2 2024 Aug 13, 2024	SELL	$143.31 - $247.0 $1.8 Million - $3.1 Million	-12,569 Reduced 2.16%	569,282 $138 Million
Q1 2024 May 14, 2024	SELL	$146.51 - $198.2 $3.94 Million - $5.33 Million	-26,877 Reduced 4.42%	581,851 $87 Million
Q4 2023 Feb 13, 2024	SELL	$151.41 - $196.57 $2.52 Million - $3.28 Million	-16,673 Reduced 2.67%	608,728 $117 Million
Q3 2023 Nov 09, 2023	SELL	$170.77 - $211.65 $3.37 Million - $4.18 Million	-19,742 Reduced 3.06%	625,401 $111 Million
Q2 2023 Aug 11, 2023	SELL	$185.01 - $212.05 $2.42 Million - $2.77 Million	-13,083 Reduced 1.99%	645,143 $123 Million
Q1 2023 May 11, 2023	SELL	$182.66 - $235.53 $9.92 Million - $12.8 Million	-54,330 Reduced 7.62%	658,226 $132 Million
Q4 2022 Feb 10, 2023	SELL	$185.53 - $241.31 $6.53 Million - $8.49 Million	-35,194 Reduced 4.71%	712,556 $169 Million
Q3 2022 Nov 14, 2022	SELL	$138.54 - $232.0 $11.1 Million - $18.6 Million	-80,329 Reduced 9.7%	747,750 $150 Million
Q2 2022 Aug 05, 2022	SELL	$120.42 - $169.29 $4.9 Million - $6.88 Million	-40,669 Reduced 4.68%	828,079 $121 Million
Q1 2022 May 13, 2022	SELL	$127.18 - $173.91 $16.2 Million - $22.2 Million	-127,689 Reduced 12.81%	868,748 $142 Million
Q4 2021 Feb 14, 2022	BUY	$159.56 - $209.29 $4.52 Million - $5.93 Million	28,330 Added 2.93%	996,437 $169 Million
Q3 2021 Nov 12, 2021	BUY	$169.75 - $207.73 $3.74 Million - $4.58 Million	22,042 Added 2.33%	968,107 $183 Million
Q2 2021 Aug 13, 2021	BUY	$128.63 - $176.89 $122 Million - $167 Million	946,065 New	946,065 $160 Million

Others Institutions Holding ALNY

# of Institutions

670

Shares Held

112M

Call Options Held

839K

Put Options Held

771K

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $30B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

News

Stay updated on Loomis Sayles & CO L P with notifications on news.

Account

Loomis Sayles & CO L P Alnylam Pharmaceuticals, Inc. Transaction History